•
Sep 30, 2022

2Seventy Bio Q3 2022 Earnings Report

Total Revenue
$13.4M
Previous year: $19.3M
-30.4%
EPS
-$1.76
Previous year: -$2.57
-31.5%
Gross Profit
$13M
Previous year: $18.9M
-31.2%
Cash and Equivalents
$127M
Free Cash Flow
-$74.3M
Previous year: -$46M
+61.7%
Total Assets
$709M
Previous year: $193M
+267.3%

2Seventy Bio

2Seventy Bio